PBYI FY 2018 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$299M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$251M+806.1% YoY

Gross Profit

$216M86.2% margin

Operating Income

-$95M-37.7% margin

Net Income

-$114M-45.3% margin

EPS (Diluted)

$-2.99

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$25M

Stock-Based Comp.

$87M

Balance Sheet

Total Assets

$259M

Total Liabilities

$225M

Stockholders' Equity

$34M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$251M	$28M	+806.1%
Gross Profit	$216M	$22M	+879.2%
Operating Income	-$95M	-$292M	+67.6%
Net Income	-$114M	-$292M	+61.1%